Drug · DIN 02459701
ORFADIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 17, 2017; first marketed February 17, 2017.
- Drug Identification Number (DIN)
- 02459701
- Company (DIN owner)
- Swedish Orphan Biovitrum Ab (Publ)Stockholm, Sweden
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Nitisinone A16AX04
- Class
- Human
- Record last updated
- July 29, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NITISINONE | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 13, 2016: NOC 18759New Drug Submission (NDS)
Other DINs named ORFADIN
- DIN 02459698 · Marketed
- DIN 02459728 · Marketed
- DIN 02459736 · Marketed
- DIN 02469693 · Marketed